Stock Spotlight Archives - Page 163 of 389

MondaySep 27, 2021 11:56 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Working to Bring Psychedelic Treatments Closer to the People

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is contributing to the ongoing conversation around the use of psychedelics in the field of medicine, thereby stamping its position as a leader in the psychedelic renaissance. This follows efforts by the scientific community in the 21st century to prove the potential of psychedelics to rewire or repair circuits in the brain. Specifically, Tryp is bringing light to psilocybin usage in diseases with high unmet needs, including chronic pain, through its Psilocybin-For Neuropsychiatric Disorders (TM) (“PFN”) program. “With its three strategic initiatives — develop, protect and monetize — Tryp remains committed to utilizing FDA’s…

MondaySep 27, 2021 11:46 am

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Spotlights Companies in Burgeoning EdTech Space at Inaugural Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, brought together some of the stars within the education technology (“EdTech”) market in the first-ever Sequire EdTech Conference. The event featured prominent virtual work and remote learning companies and touched multiple value points for SRAX by featuring a burgeoning industry as a key opinion leader, showing off its platform to potential clients and investors and spotlighting public companies in the EdTech space. With the fall season expected to again be challenging for schools following the prominence of the…

FridaySep 24, 2021 2:08 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enhancing Performance of Antiviral Drugs, CBD

Lexaria Bioscience Corp. (NASDAQ: LEXX) is making significant progress in advancing its patented DehydraTECH(TM) drug delivery technology. Lexaria recently reviewed its successful 2021 antiviral drug program. “The company has progressed significantly in evidencing that DehydraTECH can sufficiently enhance the usable fraction of known antiviral drugs that reach the bloodstream to safely and more effectively do what they are designed to accomplish,” reads a recent article. In addition to the antiviral program, Lexaria is also focused on another applied R&D program — hypertension. On July 29, it released partial results from a human clinical study, HYPER-H21-1, evaluating DehydraTECH-processed cannabidiol (“CBD”) for…

FridaySep 24, 2021 1:54 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continuing Momentum to Grow Sales, Revenue

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is a pioneer in cannabis and hemp-derived product lines, strategically positioning itself to be among the top three multistate operators of these products within the American market. In late July of this year, the company released its Q1 2021 financial results in what Brand Rogers, RWB Chairman and CEO, described as “another great quarter for the company.” A recent article reads, “When making the announcement, Mr. Rogers also noted that the company would be building on the momentum from Q1, given how much traction it had received for its brand. More…

FridaySep 24, 2021 1:39 pm

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd.’s (NASDAQ: ANPC) CDA Technology Detects Risk of Over 25 Different Cancer Types

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is a recognized innovator and leader in the field of early cancer screening and detection. Its core product and proven revenue generator, the pioneering Cancer Differentiation Analysis (“CDA”) platform, offers novel capabilities by looking for signals to help it assess the risk of cancer occurring before a tumor has developed. This approach is unlike the blood sample-based cancer screenings, which generally target protein-based biomarkers, genomic signals, such as circulating tumor DNA (“ct-DNA”), circulating in the bloodstream to determine if a cancer exists and is spreading.…

FridaySep 24, 2021 1:28 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Garners Attention as ‘Emerging Leader in the Psychedelic Therapeutics Space’

Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently released its Q1 2021 operational and financial report for the period ended June 30, 2021. The biotech company hit several milestones, including becoming the first psychedelic company to list on the NYSE American LLC stock exchange and raising more than CA$120 million. In addition, Cybin has started the next phase of its digital therapeutics platform, signed an exclusive R&D collaboration agreement with TMS NeuroHealth Centers Inc to establish Mental Health Centers of Excellence, as well as commenced scaling up its…

ThursdaySep 23, 2021 2:23 pm

QualityStocksNewsBreaks – Brain Scientific Inc.’s (BRSF) Proprietary Brain Diagnostics Devices Positioned to Profoundly Shift EEG Market

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, is leveraging artificial intelligence (“AI”) and machine learning (“ML”) to improve diagnostic capability using a database of biomarkers that collect data on both normal and abnormal brain information. Brain Scientific’s use of AI and ML is part of its overall strategy to penetrate the rapidly growing electroencephalogram (“EEG”) market. The strategy includes developing its patented FDA-cleared NeuroCap(TM) and NeuroEEG(TM) devices. NeuroCap is a disposable pre-gelled EEG headset with 22 electrodes and 19 active EEG channels that can be used to record EEGs in nearly any setting.…

ThursdaySep 23, 2021 2:03 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Committed to Increasing Market Reach, Product Line, Quality of Offerings

FingerMotion (OTCQX: FNGR) has always endeavored to deliver the next generation of data-driven technology solutions that cut across its current product line and service offerings. Even so, the company, which currently provides solutions to the Chinese market, is seeking expansion. “Going forward, it seeks to expand into other regions and further introduce other innovative offerings, mainly in collaboration with other tech companies in specific industries. So far, associations with Happy Life Insurance and Xunlian Tanxia Technology show FNGR’s commitment to this path and highlight its future,” reads a recent article. “This company is committed to growing its user base organically,…

ThursdaySep 23, 2021 1:43 pm

QualityStocksNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Witnesses Impressive First Half of 2021

AmpliTech Group (NASDAQ: AMPG) recently announced financial results for the first six months of the 2021 fiscal year, along with Q2 2021 results. “The first six months of 2021 were significant for AmpliTech,” reads a recent article. “For starters, the company completed its financial recapitalization and Nasdaq uplisting. This move allowed it to raise working capital of $29.8 million as of June 30. This capital would go into product development, sales and marketing infrastructure investments while also offering the financial strength needed to engage with global customer prospects that were previously out of the company’s reach.” The company was also…

WednesdaySep 22, 2021 3:43 pm

QualityStocksNewsBreaks – Golden Triangle Ventures Inc. (GTVH), Positron Partner to Tap into Lucrative Virtual Reality Events Space

Golden Triangle Ventures (OTC: GTVH) has partnered with Positron, a leading virtual reality (“VR”) technology and entertainment company, in a five-year agreement that places it in a strong position in the VR event space. Online pay-per-view performances became an option for artists to eke out a living following the pandemic-imposed restrictions. However, a recent article, which contains excerpts from a Forbes publication, notes that GTVH believes the real promise is in VR concerts, effectively agreeing with the Forbes piece. “Virtual reality concerts, although less common than online pay-per-view concerts, are potentially much more lucrative,” reads the article. Positron’s platform, developed…

Site Search

Company Search

Category: Stock Spotlight